I-Dato-DXd Ivunyelwe eShayina Yomdlavuza Webele Owake Welashwa Ngaphambili we-HR+, i-HER2-Negative Metastatic

Ngomhlaka-22 Agasti 2025, i-Datopotamab deruxtecan (Dato-DXd; Datroway) ithole imvume eShayina yokwelapha iziguli ezindala ezine-hormone receptor-positive engasuswa noma e-metastatic, i-HER2-negative (immunohistochemistry [IHC] 0, IHC 1+, noma i-IHC 2+/in situ hybridization [ISH] negative) umdlavuza webele ezike zathola ukwelashwa kwe-endocrine kanye nokwelashwa okungenani okukodwa kwe-chemotherapy endaweni ethuthukisiwe.

21f7babaee5b9216646d7acd3c2c0d8c.png

Njengamanje, kusenezivivinyo eziningi zemitholampilo zobuchwepheshe obusha bokulwa nomdlavuza eShayina ezifuna iziguli. Ukubonisana ngemithi emisha kanye nobuchwepheshe, ungaxhumana noMnyango Wezizwe Ngezizwe Wesibhedlela iBeijing South Region Oncology.

Inombolo yocingo: 4008803716

I-ID ye-WeChat: 17801183037

Email:myimmnet@163.com

Lokhu kuvunywa kusekelwe emiphumeleni emihle yocwaningo lwe-TROPION-Breast01 lwesigaba sesi-3 somhlaba wonke. Ucwaningo lwe-TROPION-Breast01 oluvulekile, oluhleliwe lwesigaba sesi-3, luhlole i-trophoblast cell surface antigen 2-directed antibody-drug conjugate datopotamab deruxtecan (Dato-DXd) uma kuqhathaniswa nokukhetha komcwaningi kwe-chemotherapy (ICC) kumdlavuza webele we-hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR+/HER2–).

Iziguli zabelwa ngokungahleliwe ku-Dato-DXd (n = 365) noma ku-ICC (n = 367). I-Dato-DXd inciphise kakhulu ingozi yokuqhubeka noma yokufa uma kuqhathaniswa ne-ICC (PFS by BICR hazard ratio [HR], 0.63 [95% CI, 0.52 kuya ku-0.76]; P < .0001). Inzuzo ye-PFS eqhubekayo yabonwa kuwo wonke amaqembu amancane. Nakuba idatha ye-OS yayingakavuthwa, kwabonakala ukuthambekela okukhuthaza i-Dato-DXd (HR, 0.84 [95% CI, 0.62 kuya ku-1.14]). Izinga lezehlakalo ezimbi ezihlobene nokwelashwa (ama-TRAE) ebanga ≥3 nge-Dato-DXd laliphansi kune-ICC (20.8% v 44.7%). Ama-TRAE avame kakhulu (noma yiliphi ibanga; ibanga ≥3) kwakuyisicanucanu (51.1%; 1.4%) kanye ne-stomatitis (50%; 6.4%) ene-Dato-DXd kanye ne-neutropenia (igama eliqoqwe ngamaqembu, 42.5%; 30.8%) ene-ICC.

Iziguli ezithola i-Dato-DXd zibe nokuthuthuka okuphawulekayo ngokwezibalo nokubalulekile emtholampilo ku-PFS kanye nephrofayili yokuphepha enhle nephathekayo, uma kuqhathaniswa ne-ICC.

Njengamanje, kusenezivivinyo eziningi zemitholampilo zobuchwepheshe obusha bokulwa nomdlavuza eShayina ezifuna iziguli. Ukubonisana ngemithi emisha kanye nobuchwepheshe, ungaxhumana noMnyango Wezizwe Ngezizwe Wesibhedlela iBeijing South Region Oncology.

Inombolo yocingo: 4008803716

I-ID ye-WeChat: 17801183037

Email:myimmnet@163.com

微信图片_20241115181717


Isikhathi sokuthunyelwe: Agasti-26-2025